Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
It is commonly examined in experimental settings focused on receptor-specific activity, peptide behavior, and analytical assay applications
(2024) Partial loss of MCU mitigates pathology in vivo across a diverse range of neurodegenerative disease models
7DF), indicating a dual mechanism of DMF on their regulation dependent on both NRF2 binding and DNA hydroxymethylation
10.1590/1984-3143-ar2024-0134 130 RitossaF
Hara et al
US$ 27.14
US$ 29.11
US$ 28.34
US$ 28.08
US$ 21.72
US$ 21.44
